Li-xu V. Yan
106 Zhongshan Er Rd
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.
Journal: Science translational medicine
Published: August 26, 2026
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China.
Journal: EClinicalMedicine
Published: January 25, 2026
First case report of transformation of adenocarcinoma to adenosquamous carcinoma with giant-cell carcinoma harboring HER2 mutation after zongertinib (BI 1810631) resistance.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 22, 2025
Single-cell RNA profiling reveals an immunosuppressive microenvironment in EGFR double-mutant non-small cell lung cancer.
Journal: Translational lung cancer research
Published: June 19, 2025
Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report.
Journal: Translational lung cancer research
Published: October 17, 2024
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma.
Journal: JTO clinical and research reports
Published: March 21, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Journal: Cell reports. Medicine
Published: November 02, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.
Journal: Signal transduction and targeted therapy
Published: May 24, 2023
Dynamic 18 F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer.
Journal: Thoracic cancer
Published: March 27, 2022
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
Journal: NPJ precision oncology
Published: January 23, 2022
Development and validation of a computed tomography-based immune ecosystem diversity index as an imaging biomarker in non-small cell lung cancer.
Journal: European radiology
Published: September 28, 2021
Last Updated: 09/26/2026